In this issue of Clinics in Laboratory Medicine, guest editor Dr. Alexa J. Siddon brings her considerable expertise to the topic of Myelodysplastic Syndromes. Top experts in the field discuss the various aspects of rare myelodysplastic syndromes and its treatments, detection, and characteristics. Topics include molecular changes in myelodysplastic syndromes; MDS with mutated SF3B1; myeloid neoplasms with mutated TP53; mimics of myelodysplastic syndromes; myeloid neoplasms with germline predisposition; and more.
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance) Morphologic Characteristics of Myelodysplastic Syndromes Significance of SF3B1 Mutations in Myeloid Neoplasms Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53 Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications Childhood Myelodysplastic Syndrome Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes Transfusion Support of Patients with Myelodysplastic Syndromes Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.